INSTITUTO GRIFOLS S.A.

It is used to replenish and maintain circulating blood volume in patients who have lost blood or body fluids, where the use of a plasma substitute (colloid) is appropriate.

Dosage form: solution for infusion

ATC: B05AA01

It is an anticoagulant drug used to prevent the risk of blood clot formation (such as deep vein thrombosis or thromboembolism) in people who have an antithrombin deficiency, whether present from birth or acquired later. It is used during surgical procedures or during the postpartum period, often in combination with heparin.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B01AB02

Fanhdi is used for the treatment and prevention of bleeding episodes in people with hemophilia A (factor VIII deficiency) or von Willebrand disease (when desmopressin treatment is ineffective or contraindicated). It is also indicated for the treatment of acquired factor VIII deficiency and for hemophiliacs A who have antibodies against factor VIII.

Dosage form: solution for injection, powder and solvent

ATC: B02BD06

It is used for the treatment of adults, children, and adolescents with insufficient antibody levels (such as in Primary or Secondary Immunodeficiency Syndrome) or for protection against measles. It is also indicated for several autoimmune conditions, including Primary Immune Thrombocytopenia, Guillain-Barré Syndrome, Kawasaki Disease, CIDP, and multifocal motor neuropathy.

Dosage form: solution for infusion

ATC: J06BA02

It is used to restore and maintain circulating blood volume in cases where a volume deficiency has been demonstrated and the use of a plasma substitute is deemed appropriate.

Dosage form: solution for infusion

ATC: B05AA01

It is used to prevent Rh(D) immunization in women with Rh(D) negative blood group. This occurs during pregnancy (either planned or following complications such as miscarriage, hemorrhage, or invasive procedures) and after the birth of an Rh(D) positive child. It is also indicated for treating Rh(D) negative individuals who have received incompatible blood transfusions.

Dosage form: solution for injection

ATC: J06BB01

It is used for protection following a wound that may carry a risk of tetanus (in people who are not adequately vaccinated or have poor antibody production) and for the treatment of tetanus when the disease is already manifest.

Dosage form: solution for injection

ATC: J06BB02

It is used for the prevention of hepatitis B in various cases: after accidental exposure in non-immunized persons, in patients undergoing hemodialysis, in newborns of mothers who are carriers of the virus, and in those who have not developed an immune response after vaccination. It is also indicated to prevent the recurrence of hepatitis B after a liver transplant.

Dosage form: solution for injection

ATC: J06BB04

This medicinal product is used to prevent reinfection with hepatitis B virus (HBV) in patients who have undergone a liver transplant due to liver failure caused by hepatitis B. It is also used for hepatitis B immunoprophylaxis in cases of accidental exposure in non-immunized individuals, in patients undergoing hemodialysis, in newborns born to virus-carrying mothers, and in those who have not developed an immune response following vaccination.

Dosage form: solution for infusion

ATC: J06BB04

It is used to restore and maintain circulating blood volume when a reduction in blood volume (hypovolemia) has occurred.

Dosage form: solution for infusion

ATC: B05AA01

It is used to treat various conditions in which the immune system does not function correctly. Specifically, it serves as replacement therapy for those with antibody deficiency and for the treatment of certain autoimmune diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, CIDP, and multifocal motor neuropathy.

Dosage form: solution for infusion

ATC: J06BA02

It is used for chronic therapy in subjects with alpha-1 antitrypsin deficiency. It serves to restore balance in the lungs and to prevent the worsening of pulmonary emphysema.

Dosage form: solution for infusion, powder and solvent for preparation

ATC: B02AB02

It is used to treat adults with a low platelet count caused by chronic immune thrombocytopenia (ITP), when other treatments have not been sufficiently effective.

Dosage form: tablets, film-coated

ATC: B02BX09

VeraSeal is a tissue adhesive used by surgeons during surgical procedures. It is applied to the surface of bleeding tissues to reduce bleeding when standard surgical techniques are insufficient.

Dosage form: solution for tissue adhesive

ATC: B02BC

It is used to increase antibody (immunoglobulin) levels in the blood in adults, children, and adolescents suffering from immunodeficiency, such as in primary immunodeficiency syndromes, in hypogammaglobulinemia associated with chronic lymphocytic leukemia, multiple myeloma, or after a stem cell transplant.

Dosage form: solution for injection

ATC: J06BA01